Yahoo
Paris - Delayed Quote EUR

Neovacs S.A. (ALNEV.PA)

0.0730 -0.0134 (-15.51%)
As of 4:24:52 PM GMT+1. Market Open.
View in AlphaSpace Currency in EUR All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
280.5980 323.5000 366.3460 534.2690 2.4790
Cost of Revenue
-261.1990 -261.8630 -323.9250 -504.0980 -577.4090
Gross Profit
19.3990 61.6370 42.4210 30.1710 -574.9300
Selling, General and Administrative Expenses
-1,761.3490 -1,831.4430 -3,028.8900 -3,121.1330 -1,902.5870
Depreciation, Amortization and Depletion
-232.7640 -252.1890 -7,820.2530 -5,571.8900 -482.5520
Taxes Other Than Income Taxes
-12.1580 -41.6860 -89.9260 -110.1270 -943.9540
Provision Expense/Write-Back
-439.9330 -943.6930 4.0200 4.0200 10.0770
Other Income/Expense, Operating
-2,449.2250 -2,410.5640 -2,778.7320 -3,546.5700 -2,882.2770
Operating Income/Expenses
-4,895.4290 -5,479.5750 -13,713.7810 -12,345.7000 -6,201.2930
Total Operating Profit/Loss
-4,876.0300 -5,417.9380 -13,671.3600 -12,315.5290 -6,776.2230
Total Net Finance Income/Expense
181.6700 -284.7870 -19,240.6480 3,185.9070 3,633.4940
Net Investment Income
0 -- 0 -254.3290 -191.4130
Irregular Income/Expenses
177.4060 177.2060 -1,036.4400 -236.2550 -1,011.8000
Non-Operating Income/Expenses, Total
359.0760 -107.5810 -20,277.0880 2,695.3230 2,430.2810
Pretax Income
-4,516.9530 -5,525.5190 -33,948.4480 -9,620.2070 -4,345.9410
Provision for Income Tax
426.0320 628.7010 1,034.0390 876.7570 797.4400
Net Income from Continuing Operations
-4,090.9210 -4,896.8180 -32,914.4090 -8,743.4500 -3,548.5030
Net Income after Extraordinary Items and Discontinued Operations
-4,090.9210 -4,896.8180 -32,914.4090 -8,743.4500 -3,548.5030
Net Income after Non-Controlling/Minority Interests
-4,090.9210 -4,896.8180 -32,914.4090 -8,743.4500 -3,548.5030
Net Income Available to Common Stockholders
-4,090.9210 -4,896.8180 -32,914.4090 -8,743.4500 -3,548.5030
Diluted Net Income Available to Common Stockholders
-4,090.9210 -4,896.8180 -32,914.4090 -8,743.4500 -3,548.5030
Basic EPS
-52.40k -104.19k -- -- --
Diluted EPS
-52.40k -104.19k -- -- --
Basic Weighted Average Shares Outstanding
0.0470 0.0470 -- -- --
Diluted Weighted Average Shares Outstanding
0.0470 0.0470 -- -- --
Income Statement, Supplemental
EBIT
-5,653.4850 -6,178.6260 -35,004.8480 -11,077.0400 -5,563.1090
EBITDA
-5,155.6720 -5,158.3490 -28,063.5960 -6,058.7480 -5,096.1570
Normalized EBITDA
-5,333.0780 -5,335.5550 -25,593.2900 -5,457.8420 -3,957.7460
Normalized Income
-4,251.5944 -5,053.8613 -30,519.3461 -8,197.3088 -2,618.9802
12/31/2022 - 4/21/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: